Aquilo Capital Management as of June 30, 2022
Portfolio Holdings for Aquilo Capital Management
Aquilo Capital Management holds 13 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p Biotech Etf Tr Unit Put Option (XBI) | 19.0 | $56M | 750k | 74.27 | |
| Arrowhead Pharmaceuticals (ARWR) | 14.4 | $42M | 1.2M | 35.21 | |
| Blueprint Medicines (BPMC) | 12.4 | $36M | 717k | 50.51 | |
| Merus N V (MRUS) | 11.4 | $33M | 1.5M | 22.64 | |
| Arvinas Ord (ARVN) | 11.1 | $33M | 772k | 42.09 | |
| Regenxbio Inc equity us cm (RGNX) | 9.8 | $29M | 1.2M | 24.70 | |
| Uniqure Nv SHS (QURE) | 6.2 | $18M | 972k | 18.64 | |
| Amryt Pharma Sponsored Ads | 4.5 | $13M | 1.9M | 6.99 | |
| Argenx Se Sponsored Adr (ARGX) | 3.1 | $9.1M | 24k | 378.88 | |
| Pieris Pharmaceuticals (PIRS) | 2.4 | $7.0M | 3.7M | 1.87 | |
| Genmab A/s Sponsored Ads (GMAB) | 2.4 | $7.0M | 215k | 32.49 | |
| 4d Molecular Therapeutics In (FDMT) | 2.1 | $6.0M | 862k | 6.98 | |
| Spero Therapeutics (SPRO) | 1.3 | $3.9M | 5.3M | 0.74 |
